Literature DB >> 31291178

Do patients on biologic drugs for rheumatic disease need PCP prophylaxis?

Joy-Ann Tabanor1, Santhanam Lakshminarayanan2.   

Abstract

Entities:  

Year:  2019        PMID： 31291178     DOI： 10.3949/ccjm.86a.18084

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


× No keyword cloud information.
  2 in total

Review 1.  Prevention Strategies to Minimize the Infection Risk Associated with Biologic and Targeted Immunomodulators.

Authors:  Elaheh Kordzadeh-Kermani; Hossein Khalili; Iman Karimzadeh; Mohammadreza Salehi
Journal:  Infect Drug Resist       Date:  2020-02-18       Impact factor: 4.003

2.  The Long-Acting Echinocandin, Rezafungin, Prevents Pneumocystis Pneumonia and Eliminates Pneumocystis from the Lungs in Prophylaxis and Murine Treatment Models.

Authors:  Melanie T Cushion; Alan Ashbaugh
Journal:  J Fungi (Basel)       Date:  2021-09-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.